AA
AgentAdda Market Intelligence
Comprehensive stock research | HBLENGINE

HBL ENGINEERING LIMITED (HBLENGINE)

HBL ENGINEERING LIMITED — Stage 4 setup with EFS 48.9 and investment score 40.7.

Data refreshed 4 Sep 2026. Stage snapshot: 2026-08-17; technical indicators as-of: 2026-09-03. Prices are delayed/EOD unless explicitly marked otherwise. Financials in INR crore unless stated.

Market capINR 19,519 CrScreener / PG financials
P/E24.3xTrailing
Jun 2026 revenue638 CrYoY +6.0%
Jun 2026 PAT109 CrYoY -23.8%
ROCE58.4%Screener / PG financials
ROE45.3%Screener / PG financials
Book valueINR 79.9Per share
Vol ratio (EOD)0.62xVs 20D avg

Investment Read

Treat FY2025-26 as a breakout year, but do not assume linearity: management explicitly warns that sales/PBT will vary and that the flagship Kavach business can see margin volatility.

The core question is durability: can HBL diversify away from Kavach before competition and contract-mix normalise margins?

What changed in FY2025-26: the annual report shows a sharp step-up in scale and profitability (headline: revenue ~₹3,252 Cr and PAT ~₹797 Cr), plus strong operating cash generation. The same report also flags that quarterly profitability will vary (especially due to Kavach contract mix).

Future setup (company’s own framing): management describes a portfolio of nine business units, with four expected to contribute most over the next ~4 years: Kavach, industrial Ni-Cd batteries, electronic fuzes, and electric drive trains for trucks. It also frames a FY2030 scenario of >₹5,000 Cr sales as a scenario, not a prediction.

Bull case: Kavach execution leadership sustains near-term cash flows; defence approvals (electronic fuzes) convert into repeat orders; industrial batteries (especially Ni-Cd + exports) remain a steady engine; and the EV drivetrain platform reaches a commercial scale without heavy dilution.

Bear case: Kavach becomes more competitive (margin compression + slower order conversion), revenue recognition and project-cost estimation create earnings volatility, batteries face mix/price pressure (telecom shift toward lithium), and newer bets (EV drivetrain/startup investments) absorb capital without commensurate returns.

What it means for long-term investors: treat HBL as a high-variance, engineering-led portfolio. Confidence should rise only if (1) profit pool broadens beyond Kavach, (2) audited cash conversion stays strong, and (3) capital allocation remains disciplined (R&D/dividends vs non-core equity-market/startup deployments).

What it means for traders: the current technical snapshot is defensive (Supertrend SELL, price below key moving averages). That usually means: prefer defined-risk setups (pullbacks to support, breakout + retest, or trend flip confirmation) over chasing. A cleaner trend setup would typically require a sustained reclaim of SMA20/50, improving RSI, and a Supertrend flip.

Decision Frame

  • Business: engineering-led portfolio across rail safety (Kavach), industrial/defence batteries, defence fuzes, and EV drivetrain.
  • Durability check: does profit concentration reduce over the next 4–8 quarters (Kavach share vs others)?
  • Cash + capital allocation: CFO vs PAT, and how surplus cash is deployed (R&D/dividends vs non-core investments).
  • Technical: Stage 4, RSI 43.0, Supertrend SELL; avoid low-quality chases in Stage 4.
  • Invalidation: evidence of Kavach margin compression persisting, weak cash conversion, or a fresh trend breakdown after any attempted reversal.

Fundamental Scores

Agent Adda scores from snapshot (Agent Adda cached snapshot). Useful ranking signals — not standalone buy/sell rules.

Enhanced fund score48.9
Investment score40.7
Earnings quality93.8
Sales growth95.0
Financial strength93.0
Institutional bias65.0
Technical score19.3

Score Interpretation

EFS 48.9 is the composite fundamental score: it indicates a reasonably strong combination of earnings quality (93.8), sales growth (95.0), financial strength (93.0), and institutional bias (65.0). The weaker sales-growth/financial-strength components are why the score is not a clean quality signal. Investment Score 40.7 is lower because it blends the fundamental stack with the current technical setup, where the technical score is 19.3. In plain English: the tape is stronger than the balance-sheet evidence, so the stock can screen well for momentum without removing execution, leverage, or valuation risk. Validate the scores against audited cash flow, debt, margins, dilution, and the next two quarters before treating them as conviction.

Scores are ranking outputs, not intrinsic value. A high Investment Score can fall quickly if price momentum breaks; EFS should improve only when operating quality and cash conversion improve.

Company Overview

Business profile is grounded in the FY2025-26 annual report + NSE iXBRL/filings; treat all forward-looking statements as management claims.

What they do

HBL positions itself as a company that fills “technology gaps” via in-house R&D and niche manufacturing. It operates across industrial electronics (rail signalling/Kavach), industrial batteries (lead, Ni-Cd, lithium), and defence (batteries + electronic fuzes).

Why it can win

If proprietary design + execution know-how is real (and repeatable), niches can sustain pricing and margins. Kavach leadership and defence-qualification barriers are the two biggest potential moats.

What can go wrong

Project businesses can be lumpy and accounting-judgment heavy; dependence on one profit pool (Kavach) can amplify volatility when competition rises or contract mix shifts.

Historical P&L

Primary-source 5-year snapshot from the FY2025-26 annual report. This is a headline table; reconcile segment-mix, order execution timing, and any exceptional items with the audited notes.

PeriodRevenueOp. ProfitOPMPATEPSPayout
Mar 20231,36915111%983.5613%
Mar 20242,23342319%28010.135%
Mar 20251,96739320%2769.9910%
Mar 20263,3031,11334%81429.403%
TTM3,3391,06832%78028.17
1,369Mar 2023
2,233Mar 2024
1,967Mar 2025
3,303Mar 2026
3,339TTM

Quarterly Results

6 quarterly periods are available. Jun 2026 revenue was 638 Cr and PAT 109 Cr; the latest sequential change was revenue +5.6% and PAT +70.3%. Use the next filing to test whether the latest growth rate is recurring and whether operating margin and cash conversion are moving with earnings. Primary-source cross-check (NSE iXBRL Q3 FY26): Revenue from ops ₹874.04 Cr; PAT ₹217.56 Cr; segment revenue: Industrial Batteries: 346.66 Cr | Defence & Aviation Batteries: 39.07 Cr | Electronics: 473.34 Cr.

QuarterRevenueOp. ProfitOPMPATEPS
Mar 20254767917%451.62
Jun 202560219232%1435.17
Sep 20251,22354444%38713.97
Dec 202587430235%2207.96
Mar 20266047512%642.30
Jun 202663814723%1093.94

Balance Sheet And Cash Flow

3 balance-sheet/cash-flow periods are available. Latest reported borrowings are 67 Cr, CFO is 738 Cr, and FCF is 618 Cr. Read these alongside PAT, working-capital movements, capex, and financing flows: profit growth is higher quality when it converts to operating cash without repeated debt or equity funding.

Balance sheet itemMar 2024Mar 2025Mar 2026
Equity Capital282828
Reserves1,1931,4552,187
Borrowings+677467
Total Liabilities1,6541,9802,942
Fixed Assets+354397441
Total Assets1,6541,9802,942
Cash flow itemMar 2024Mar 2025Mar 2026
CFO270239738
CFI-137-320-214
CFF-42-26-113
FCF204120618
Net Cash91-107411
Cash conversion is the key counterweight to the reported profit trend. Reconcile CFO versus PAT, inventory and receivables, capex, borrowings, and financing inflows against the audited annual report and latest exchange filing before increasing confidence in the thesis.

Concall, Filings And News

Evidence reviewed: 4 concall artifacts and 6 exchange/company announcements. The read-through below distinguishes reported numbers, management claims, and checks required before relying on the catalyst.

Annual report and management read-through

Concall evidence and what to test

  • Coverage note: dated presentation links were found, but transcript text was not locally extracted; the materials require manual review before management claims are treated as evidence.
  • Sep 2025: Transcript | Audio
  • Jul 2024: Audio
  • Sep 2023: PPT
  • Feb 2023: PPT

Recent announcements and implications

  • 3 Sep · Book-Closure For The Purpose Of AGM
  • 3 Sep · Record Date For Determination Of Eligibility For Dividend, If Declared And To E-Vote On The Resolutions.
  • Reg. 34 (1) Annual Report.3 Sep- 40th AGM on September 26, 2026; FY26 annual report circulated, remote e-voting Septembe
  • 8 Aug · Record Date For Dividend
  • Statement Of Deviation Of Funds For The Quarter June 30, 30368 Aug- No deviation in issue proceeds use for quarter ended
  • HBL Engineering — FY2025-26 Annual Report (company site PDF): Annual Report 2025-26 (FY26): segment framing (Kavach / batteries / defence), 5-year snapshot (revenue, PAT, CFO), and management outlook (FY30 scenario guidance).
  • NSE filing — Information to shareholders (24 May 2026): Explains FY26 vs FY25 improvement, Q4 profitability variability (Kavach contract mix + provisions/R&D), and warns that quarterly profitability will vary.
This section separates reported facts, management claims, and verification tasks. Read announcements as potential catalysts only: confirm the next exchange result, balance-sheet movement, cash-flow statement, and any dilution or project milestones before changing the thesis.

NSE filings & documents digest

Newest exchange filings + extracted highlights (verify the source PDF/XBRL before thesis).

Primary NSE / exchange trail (quick digest)

Critical read: treat every “order book” or “FY30 scenario” statement as a management claim until corroborated by exchange-filed documents and audited notes. For project businesses, profitability is often contract-mix and execution-timing dependent.

📋 Annual Report Deep-Read — FY2025-26

Annual report (company site PDF). Use this as the primary narrative source; reconcile figures with audited statements and NSE/BSE filings.  📄 View Annual Report PDF

Key Financials (from AR)

Turnover₹3,252 Cr (5-year snapshot, FY2025-26)
PAT₹797 Cr (5-year snapshot, FY2025-26)
Net Worth₹2,172 Cr (5-year snapshot, as of Mar-2026)
EPS₹29 (5-year snapshot, FY2025-26)
Book Value / Share₹78 (5-year snapshot, as of Mar-2026)
Dividend / Share₹3 (interim + final, FY2025-26; face value ₹1)
ExportsExports: ₹520 Cr; Imports: ₹253 Cr (5-year snapshot, FY2025-26)

Chairman's Highlights

  • Strategy: fill technology gaps via in-house R&D and niche manufacturing; avoid capital-intensive and B2C businesses.
  • Business segments: Industrial Electronics (incl. Kavach/rail signalling), Industrial Batteries (lead / Ni-Cd / lithium), Defence (batteries + electronic fuzes).
  • Kavach: contributed ~50% of FY26 sales; management expects continued good sales in FY27–FY28 but expects competition to rise and both sales/PBT could decline from FY29 onward; quarterly margins can vary with contract mix and execution timing.
  • FY30 scenario (not a prediction): management suggests more than ₹5,000 Cr sales by FY2030 across businesses, with variability expected year-to-year.
  • Capital allocation intent: surplus cash potentially allocated across higher R&D, higher dividends, PE/startup investments, and then secondary-market investments for liquidity (board to decide annually).

Management Outlook (MD&A)

The annual report explicitly warns that growth and margins will not be uniform quarter-to-quarter; the near-term earnings engine is Kavach, while the medium-term diversification hinges on industrial Ni-Cd batteries, electronic fuzes approvals, and commercialisation of electric drivetrain programs.

Key Contracts Signed

Not extracted.

New Products / Platforms

Not extracted.

SWOT — Strengths

  • Engineering-led portfolio across multiple niches; potential moat where technology is owned and qualification barriers exist (rail safety + defence).
  • Strong FY2025-26 cash generation (headline CFO in the 5-year snapshot) supports optionality if capital allocation is disciplined.

Weaknesses

  • High variance: project/contract mix and approval cycles can cause earnings volatility.
  • Profit concentration risk (Kavach) increases sensitivity to competition, execution delays, and margin normalisation.

Key Risks

  • Kavach profit concentration + competition risk from FY29 onward (management claim).
  • Accounting/estimation risk in project execution (cost-to-complete, provisions, maintenance obligations).
  • Battery mix disruption (telecom shift toward lithium) impacting legacy lines.
  • Defence approvals can be slow and order flow lumpy (testing/qualification dependent).
  • Capital allocation drift into non-core investments (startups/markets) could dilute returns if not ROI-driven.
Working Capital Note: Project + defence execution creates working-capital swings; validate CFO vs PAT and contract assets/liabilities in audited notes.

Sector And Competitive Context

Sector and peer claims are shown only when a same-date comparable dataset is available.

LensRead-through
SectorOther
Data qualityNo peer ranking asserted without comparable same-date observations.
Next checkCompare growth, margins, balance-sheet risk, valuation, and relative strength with the company’s listed peers.

Peer ranking omitted: no comparable same-date peer dataset was supplied, so this report does not manufacture a self-comparison row.

Equity Chart V1

EOD chart from Agent Adda cached price history (130 bars). Range: 2026-02-10 → 2026-08-17.

HBLENGINE equity chart (cached EOD)

Open interactive: charts/HBLENGINE_chart.html. Generated from Agent Adda cached price history.

Chart read-through: compare price with the moving-average stack, momentum, trend strength and volume. Treat the chart as timing context; it does not replace the operating and valuation evidence above.

Technical Analysis

Technical setup from cached snapshot (if available).

IndicatorValueNote
StageStage 4Weinstein stage
SignalSELLSnapshot
RSI43.0Momentum
ADX31.0Trend strength
SMA20/50/200683.17 / 724.61 / 769.08Trend context
SupertrendSELLTrend filter
RatioValue
Market capINR 19,519 Cr
P/E24.3x
ROCE58.4%
ROE45.3%
Book valueINR 79.9
High / Low1122.0 / 570.0
Dividend yield0.42%

Weinstein And O'Neil Read

Stan Weinstein Stage Analysis

The snapshot labels the stock Stage 4 (Stage 4 downtrend). Weinstein stage describes the position of price within a multi-month trend: Stage 1 is a base, Stage 2 an advance, Stage 3 a topping range, and Stage 4 a decline. It is a context framework, not a forecast or standalone trade signal.

Evidence check: price is not above all the 20/50/200-day averages, and the moving averages are not fully stacked bullishly (683.17 / 724.61 / 769.08). RSI is 43.0 (weak momentum); ADX is 31.0 (strong trend); Supertrend is SELL. A bullish stage with weak momentum, a broken moving-average stack, or a conflicting Supertrend reading is a lower-quality setup.

Stage 2 confirmation requires a sustained advance, a successful breakout or higher low, constructive volume/relative strength, and a retest that holds. Do not infer confirmation from one strong candle; define the invalidation level before entry and avoid chasing an extended move.

William O’Neil / CAN SLIM Lens

  • C — Current earnings: latest PAT growth is -23.8% and revenue growth is +6.0%; confirm the next two quarters and check whether margin and CFO support the growth.
  • A — Annual earnings: latest annual revenue growth is +67.9%; fill the missing periods before claiming a multi-year CAGR.
  • N — New: identify a new product, customer, capacity addition, or catalyst and distinguish company guidance from delivered results.
  • S — Supply/demand: price/volume confirmation matters; share issuance, promoter selling, or thin liquidity can weaken the setup.
  • L — Leader: relative strength is 24.3; compare against the correct sector and Nifty benchmark rather than using price alone.
  • I — Institutions: institutional-bias score is 65.0; verify actual ownership trend.
  • M — Market: confirm that the broader index and sector are supportive.

Practical conclusion: watchlist-quality setup only when earnings acceleration, leadership, volume, and a definable risk point align.

Broker And Market View

Broker/analyst evidence is shown only when dated source results are returned.

No dated broker/analyst target was returned in this refresh.

Valuation Scenarios

Illustrative valuation from TTM EPS and P/E multiples (not a recommendation).

ScenarioTTM EPSP/EImplied valuevs currentCondition required
Bear (multiple compression)28.1717x479-32%Risk-off, slower growth, lower multiple.
Base (current multiple)28.1724x685-3%Steady execution; multiple holds.
Bull (multiple expansion)28.1729x821+17%Sustained growth + quality premium.

Issues And Risks

HBLENGINE-specific risks from the annual-report narrative + project/defence-business realities; validate against the audited notes and the newest NSE filings.

RiskWhy it mattersSeverityWhat to monitor
Kavach concentration + competitionKavach is a large profit pool; contract mix and future competitive intensity can compress margins and increase volatility.HighOrder inflow, execution pace, margin trend, competitor wins, and customer feedback.
Revenue recognition / estimation riskProject execution requires cost-to-complete estimates; errors can swing reported profits and create unpleasant surprises.HighDisclosures on contract assets/liabilities, provisions, and auditor KAMs.
Defence approvals + order lumpinessElectronic fuzes and defence products depend on testing/qualification and budget cycles; timing can be lumpy.MediumApproval milestones, tender pipeline, and repeat orders.
Battery mix disruptionTelecom + industrial tech shifts (e.g., toward lithium) can pressure legacy product lines and pricing.MediumSegment mix, realisations, exports, and capacity utilisation.
Capital allocation driftSurplus cash deployment into startups/markets can create non-core risk if not disciplined.MediumDividend policy adherence, disclosed investments, and ROI / write-offs.
Technical downtrend risk (for traders)Stage 4 + Supertrend SELL raises whipsaw risk and reduces edge for aggressive longs.MediumTrend flip confirmation, SMA reclaims, volume confirmation, and defined invalidation levels.

Evidence Trail

Source-first trail for review.